“…Mortality varies from 26 to 38% [11,12] -significantly greater than that predicted by the admission APACHE (Acute Physiology and Chronic Health Evaluation) scores [11] . Delayed diagnosis appears to be an important contributor to mortality, cited reasons being the atypical radiological presentations and initial sputa not showing AFB [11,12] . Another contributor is the anti-mycobacterial therapy which is predominantly orally administered.…”